US 12,103,943 B2
Development of novel clofarabine analogs for cancer therapy
Omar Moukha-Chafiq, Hoover, AL (US); Corinne Elizabeth Augelli-Szafran, Homewood, AL (US); Rebecca Boohaker, Birmingham, AL (US); Larry D. Bratton, Birmingham, AL (US); Marina Fosso Yatchang, Chelsea, AL (US); and Anish K. Vadukoot, Nashville, TN (US)
Assigned to Southern Research Institute, Birmingham, AL (US)
Filed by Southern Research Institute, Birmingham, AL (US)
Filed on Oct. 26, 2022, as Appl. No. 17/974,229.
Claims priority of provisional application 63/272,147, filed on Oct. 26, 2021.
Prior Publication US 2023/0138433 A1, May 4, 2023
Int. Cl. C07H 19/16 (2006.01); A61P 35/00 (2006.01); C07H 19/20 (2006.01)
CPC C07H 19/16 (2013.01) [A61P 35/00 (2018.01); C07H 19/20 (2013.01)] 3 Claims
 
1. A compound having a structure:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.